Apolipoprotein L1 (APOL1) and Nephropathy
No hay miniatura disponible
Archivos
Fecha
2026
Autores
Yael Szyferman, Alanis
Kleppe, Soledad
Cristiano, Fabrizio
Conde-Manotas, Juan C.
Cadena-Bonfanti, Andrés
Aroca-Martinez, Gustavo
Musso, Carlos G.
Título de la revista
ISSN de la revista
Título del volumen
Editor
Società Italiana di Nefrologia
Resumen
Introduction. End-stage renal disease exhibits a disproportionate prevalence among Black individuals and older adults within the United States and worldwide. A significant genetic contributor to this disparity is the Apolipoprotein L1 (APOL1) gene, found exclusively in populations of African ancestry. Materials and Method. We aim to perform a narrative review regarding the current understanding of APOL1 and its complex role in kidney disease pathogenesis. Results. The G1 and G2 APOL1 risk alleles are strongly associated with an elevated risk for non-diabetic chronic kidney disease (CKD), including hypertensive nephropathy, focal segmental glomerulosclerosis, and HIV-associated nephropathy, in individuals who are homozygous or compound heterozygous for these variants. While 10-15% of African Americans carry two APOL1 risk alleles, approximately 80% remain disease-free, suggesting incomplete penetrance and the involvement of additional risk factors. In this condition, renal damage could be induced through different mechanisms such as altered cellular ion transport, mitochondrial dysfunction, and the requirement for additional stressors or “second hits”. Conclusion. The increased susceptibility to end-stage renal disease (ESRD) in individuals of African ancestry is influenced by variations in the APOL1 gene.